United Therapeutics buy JPMorgan Chase & Co.
Start price
21.05.24
/
50%
€255.10
Target price
21.05.25
€276.33
Performance (%)
6.82%
End price
22.05.25
€272.50
Summary
This prediction ended on 22.05.25 with a price of €272.50. The BUY prediction by JPMorgan_Chase___Co_ finished with a performance of 6.82%. JPMorgan_Chase___Co_ has a follow-up prediction for United Therapeutics where he still thinks United Therapeutics is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| United Therapeutics | 1.226% | 1.226% | 21.747% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at JPMorgan Chase & Co. from $280.00 to $300.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat
In the thread Trading United Therapeutics
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€255.00
21.04.25
21.04.25
€309.35
21.04.26
21.04.26
65.10%
12.12.25
12.12.25
Stopped prediction by JPMorgan_Chase___Co_ for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€250.20
08.07.25
08.07.25
€281.09
08.07.26
08.07.26
64.95%
12.12.25
12.12.25
United Therapeutics
Start price
Target price
Perf. (%)
€260.00
01.05.25
01.05.25
€309.54
01.05.26
01.05.26
61.92%
12.12.25
12.12.25